Welcome to the Immuneering conference call to discuss the positive 12-month overall survival update from the company's ongoing Phase IIa trial of atebemetinib in first-line pancreatic cancer patients.
Good morning, everyone. Welcome to the Zenas Biopharma Conference Call. [Operator Instructions] Be advised that this call is being recorded at the company's request, and a replay will be available in ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap S&P 500 stocks to invest in now. On January 12, Bristol-Myers Squibb announced positive topline results from its Phase 3 SCOUT-HCM clinical ...
NMRA-511 demonstrated a 15.7 reduction on mean CMAI total score, representing a clinically meaningful effect NMRA-511 demonstrated unsurpassed clinical effect size on CMAI total score in a ...
- Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction in risk of IgG4-RD flare - - Obexelimab also met and demonstrated ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the ...
For the third quarter, the difference between our GAAP results and adjusted results consists of the following items, ...
The melting of materials seems like a simple phenomenon. However, when their thickness is reduced to just a few atoms, established rules waver. In this two-dimensional mode, new states emerge between ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sNDA) for AUGTYRO™ ...
Mediawan will also collaborate with BYD on content in various ways, ranging from brand integration in select titles across Mediawan Group productions. This include featuring BYD vehicles in upcoming ...
Domestic brokerage firms continue to remain largely positive on Indus Tower Ltd, a leading provider of passive telecom infrastructure. They are swearing by its strategic positioning and growth ...